Treatment of complement-associated disorders
The present invention concerns a recently discovered macrophage specific receptor, STIgMA, and its use in the treatment of complement-associated disorders.
Genentech, Inc.
C C C Y C Y A
C07K C07K C07K Y10S C07K Y10S A61K
inventional inventional additional additional additional additional additional
Sherman William I. Avi Kenneth James Austin L. Mary A. Daniel Audrey Menno Karim Yussef
Fong Wood Ashkenazi Katschke, Jr. Gurney Napier Tumas Goddard Van Lookeren Helmy